Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach.

Fredrik Nyberg, Johan Askling, Niklas Berglind, Stefan Franzén, Meilien Ho, Marie Holmqvist, Laura Horne, Kathy Lampl, Kaleb Michaud, Dimitrios A Pappas, George Reed, Deborah Symmons, Eiichi Tanaka, Trung N Tran, Suzanne Verstappen, Eveline Wesby-van Swaay, Hisashi Yamanaka, Jeffrey D Greenberg

    Research output: Contribution to journalArticlepeer-review

    Search results